| Year |
Citation |
Score |
| 2019 |
Guo T, Luna A, Rajapakse VN, Koh CC, Wu Z, Liu W, Sun Y, Gao H, Menden MP, Xu C, Calzone L, Martignetti L, Auwerx C, Buljan M, Banaei-Esfahani A, ... ... Iskar M, et al. Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines. Iscience. 21: 664-680. PMID 31733513 DOI: 10.1016/J.Isci.2019.10.059 |
0.597 |
|
| 2019 |
Chun HE, Johann PD, Milne K, Zapatka M, Buellesbach A, Ishaque N, Iskar M, Erkek S, Wei L, Tessier-Cloutier B, Lever J, Titmuss E, Topham JT, Bowlby R, Chuah E, et al. Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration. Cell Reports. PMID 31708418 DOI: 10.1016/J.Celrep.2019.10.013 |
0.312 |
|
| 2019 |
Mallm JP, Iskar M, Ishaque N, Klett LC, Kugler SJ, Muino JM, Teif VB, Poos AM, Großmann S, Erdel F, Tavernari D, Koser SD, Schumacher S, Brors B, König R, et al. Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks. Molecular Systems Biology. 15: e8339. PMID 31118277 DOI: 10.15252/Msb.20188339 |
0.304 |
|
| 2019 |
Schramm K, Iskar M, Statz B, Jäger N, Haag D, Słabicki M, Pfister SM, Zapatka M, Gronych J, Jones DTW, Lichter P. DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for DIPGs. Neuro-Oncology. PMID 30943283 DOI: 10.1093/Neuonc/Noz057 |
0.311 |
|
| 2016 |
Scharaw S, Iskar M, Ori A, Boncompain G, Laketa V, Poser I, Lundberg E, Perez F, Beck M, Bork P, Pepperkok R. The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR. The Journal of Cell Biology. 215: 543-558. PMID 27872256 DOI: 10.1083/Jcb.201601090 |
0.43 |
|
| 2016 |
Deghou S, Zeller G, Iskar M, Driessen M, Castillo M, van Noort V, Bork P. CART - a chemical annotation retrieval toolkit. Bioinformatics (Oxford, England). PMID 27256313 DOI: 10.1093/Bioinformatics/Btw233 |
0.732 |
|
| 2016 |
Ori A, Iskar M, Buczak K, Kastritis P, Parca L, Andrés-Pons A, Singer S, Bork P, Beck M. Spatiotemporal variation of mammalian protein complex stoichiometries. Genome Biology. 17: 47. PMID 26975353 DOI: 10.1186/S13059-016-0912-5 |
0.461 |
|
| 2015 |
Iskar M, Bork P, van Noort V. Discovery and validation of the antimetastatic activity of citalopram in colorectal cancer. Molecular & Cellular Oncology. 2: e975080. PMID 27308430 DOI: 10.4161/23723556.2014.975080 |
0.696 |
|
| 2015 |
Ori A, Toyama BH, Harris MS, Bock T, Iskar M, Bork P, Ingolia NT, Hetzer MW, Beck M. Integrated Transcriptome and Proteome Analyses Reveal Organ-Specific Proteome Deterioration in Old Rats. Cell Systems. 1: 224-237. PMID 27135913 DOI: 10.1016/J.Cels.2015.08.012 |
0.476 |
|
| 2015 |
Mackmull MT, Iskar M, Parca L, Singer S, Bork P, Ori A, Beck M. Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs). Molecular & Cellular Proteomics : McP. 14: 1350-60. PMID 25755299 DOI: 10.1074/Mcp.M114.042499 |
0.51 |
|
| 2015 |
Ori A, Toyama BH, Harris MS, Bock T, Iskar M, Bork P, Ingolia NT, Hetzer MW, Beck M. Integrated Transcriptome and Proteome Analyses Reveal Organ-Specific Proteome Deterioration in Old Rats Cell Systems. 1: 224-237. DOI: 10.1016/j.cels.2015.08.012 |
0.362 |
|
| 2014 |
Durdu S, Iskar M, Revenu C, Schieber N, Kunze A, Bork P, Schwab Y, Gilmour D. Luminal signalling links cell communication to tissue architecture during organogenesis. Nature. 515: 120-4. PMID 25337877 DOI: 10.1038/Nature13852 |
0.431 |
|
| 2014 |
van Noort V, Schölch S, Iskar M, Zeller G, Ostertag K, Schweitzer C, Werner K, Weitz J, Koch M, Bork P. Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling. Cancer Research. 74: 5690-9. PMID 25038229 DOI: 10.1158/0008-5472.Can-13-3540 |
0.74 |
|
| 2013 |
Iskar M, Zeller G, Blattmann P, Campillos M, Kuhn M, Kaminska KH, Runz H, Gavin AC, Pepperkok R, van Noort V, Bork P. Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding. Molecular Systems Biology. 9: 662. PMID 23632384 DOI: 10.1038/Msb.2013.20 |
0.737 |
|
| 2013 |
Ori A, Banterle N, Iskar M, Andrés-Pons A, Escher C, Khanh Bui H, Sparks L, Solis-Mezarino V, Rinner O, Bork P, Lemke EA, Beck M. Cell type-specific nuclear pores: a case in point for context-dependent stoichiometry of molecular machines. Molecular Systems Biology. 9: 648. PMID 23511206 DOI: 10.1038/Msb.2013.4 |
0.491 |
|
| 2013 |
Pacini C, Iorio F, Gonçalves E, Iskar M, Klabunde T, Bork P, Saez-Rodriguez J. DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data. Bioinformatics (Oxford, England). 29: 132-4. PMID 23129297 DOI: 10.1093/Bioinformatics/Bts656 |
0.613 |
|
| 2012 |
Iskar M, Zeller G, Zhao XM, van Noort V, Bork P. Drug discovery in the age of systems biology: the rise of computational approaches for data integration. Current Opinion in Biotechnology. 23: 609-16. PMID 22153034 DOI: 10.1016/J.Copbio.2011.11.010 |
0.778 |
|
| 2011 |
Zhao XM, Iskar M, Zeller G, Kuhn M, van Noort V, Bork P. Prediction of drug combinations by integrating molecular and pharmacological data. Plos Computational Biology. 7: e1002323. PMID 22219721 DOI: 10.1371/Journal.Pcbi.1002323 |
0.784 |
|
| 2011 |
Brouwers L, Iskar M, Zeller G, van Noort V, Bork P. Network neighbors of drug targets contribute to drug side-effect similarity. Plos One. 6: e22187. PMID 21765950 DOI: 10.1371/Journal.Pone.0022187 |
0.771 |
|
| 2010 |
Iskar M, Campillos M, Kuhn M, Jensen LJ, van Noort V, Bork P. Drug-induced regulation of target expression. Plos Computational Biology. 6. PMID 20838579 DOI: 10.1371/Journal.Pcbi.1000925 |
0.739 |
|
| Show low-probability matches. |
